BAJAJ HEALTHCARE
|
BAJAJ HEALTHCARE Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -5.19 | 23.02 | 25.87 | 60.23 | 18.29 |
| CEPS(Rs) | 4.82 | 29.26 | 32.26 | 35.96 | 13.54 |
| DPS(Rs) | 1.00 | 1.00 | 1.50 | 2.75 | - |
| Book NAV/Share(Rs) | 100.86 | 133.23 | 119.02 | 187.26 | 128.94 |
| Tax Rate(%) | 14.09 | 18.74 | 20.40 | 30.05 | 30.02 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 8.06 | 8.63 | 17.45 | 20.76 | 11.78 |
| EBIT Margin(%) | 1.38 | 7.42 | 15.07 | 19.35 | 10.41 |
| Pre Tax Margin(%) | -1.76 | 6.05 | 13.19 | 18.09 | 8.79 |
| PAT Margin (%) | -1.51 | 4.92 | 10.50 | 12.65 | 6.16 |
| Cash Profit Margin (%) | 1.40 | 6.25 | 13.09 | 15.10 | 9.11 |
| Performance Ratios | |||||
| ROA(%) | -1.74 | 7.84 | 11.45 | 19.14 | 8.28 |
| ROE(%) | -4.44 | 18.25 | 24.33 | 38.09 | 18.92 |
| ROCE(%) | 1.88 | 14.02 | 20.00 | 35.91 | 19.47 |
| Asset Turnover(x) | 1.15 | 1.59 | 1.09 | 1.51 | 1.34 |
| Sales/Fixed Asset(x) | 2.00 | 2.79 | 1.86 | 2.20 | 1.67 |
| Working Capital/Sales(x) | 388.92 | 19.33 | 8.92 | 8.67 | 13.31 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.50 | 0.36 | 0.54 | 0.45 | 0.60 |
| Receivable days | 72.17 | 53.51 | 76.07 | 54.82 | 78.61 |
| Inventory Days | 68.01 | 52.00 | 68.82 | 37.89 | 30.86 |
| Payable days | 124.77 | 90.43 | 78.13 | 61.06 | 60.64 |
| Valuation Parameters | |||||
| PER(x) | - | 13.24 | 13.16 | 3.92 | 5.62 |
| PCE(x) | 60.73 | 10.42 | 10.55 | 6.56 | 7.60 |
| Price/Book(x) | 2.90 | 2.29 | 2.86 | 2.52 | 1.59 |
| Yield(%) | 0.34 | 0.33 | 0.44 | 0.58 | - |
| EV/Net Sales(x) | 2.40 | 1.91 | 1.76 | 1.24 | 0.90 |
| EV/Core EBITDA(x) | 13.37 | 10.93 | 9.94 | 5.70 | 6.76 |
| EV/EBIT(x) | 86.93 | 12.89 | 11.65 | 6.43 | 8.68 |
| EV/CE(x) | 1.86 | 1.58 | 1.66 | 1.56 | 1.08 |
| M Cap / Sales | 1.71 | 1.30 | 1.38 | 0.99 | 0.69 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -26.69 | -5.01 | 3.49 | 60.24 | 26.15 |
| Core EBITDA Growth(%) | -24.81 | -5.86 | -16.18 | 161.40 | 24.87 |
| EBIT Growth(%) | -86.36 | -6.45 | -19.42 | 197.86 | 31.41 |
| PAT Growth(%) | -122.55 | -11.00 | -14.11 | 229.32 | 54.73 |
| EPS Growth(%) | -122.55 | -11.00 | -57.05 | 229.32 | -22.64 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 1.19 | 1.13 | 0.78 | 0.70 | 0.51 |
| Current Ratio(x) | 1.01 | 1.15 | 1.24 | 1.41 | 1.22 |
| Quick Ratio(x) | 0.65 | 0.67 | 0.74 | 0.88 | 0.94 |
| Interest Cover(x) | 0.44 | 5.42 | 8.02 | 15.25 | 6.44 |
| Total Debt/Mcap(x) | 0.41 | 0.49 | 0.27 | 0.28 | 0.32 |
Compare Financial Ratios of peers of BAJAJ HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAJAJ HEALTHCARE | ₹1,687.3 Cr | 11.6% | 38.6% | 50.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,920.0 Cr | -0.1% | 1.7% | 45.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,160.0 Cr | -0.1% | -2.2% | 56.9% | Stock Analytics | |
| CIPLA | ₹118,917.0 Cr | 1.7% | 0.5% | 23.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,017.0 Cr | 5.7% | 12.4% | 18.5% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹97,997.1 Cr | -1.4% | 3.1% | 44.8% | Stock Analytics | |
BAJAJ HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAJAJ HEALTHCARE | 11.6% |
38.6% |
50.1% |
| SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses
